“The Postoperative Pain market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Postoperative Pain pipeline products will significantly revolutionize the Postoperative Pain market dynamics”

 

The Postoperative Pain market report provides current treatment practices, Postoperative Pain emerging drugs, market share of individual therapies, and current and forecasted 7MM Postoperative Pain market size from 2019 to 2032. The report also covers current Postoperative Pain treatment market practices/algorithms and unmet medical needs to curate the best opportunities and assess the market’s underlying potential.

 

Key Takeaways from the Postoperative Pain Market Research Report

• In 2022, the US captured the highest market share (85%), followed by Japan (7%), out of all the 7MM countries.
• The Postoperative Pain market size in the 7MM will increase at a CAGR of 7.2% due to an increase in surgical procedures being carried out and the launch of emerging therapies.
• The leading companies working in the Postoperative Pain Market include Taiwan Liposome Company, Teikoku Pharma USA, Novartis Pharmaceuticals, Concentric Analgesics, Mati Therapeutics, Arthritis Innovation Corporation, MedinCell, Surface Ophthalmics, Salvat Laboratories, Grünenthal, Vertex Pharmaceuticals, Formosa Pharmaceuticals, Oculis, Neumentum Pharmaceuticals, Charleston Laboratories, and others.
• Promising Postoperative Pain Pipeline Therapies in the various stages of development include SABER-Bupivacaine Treatment 1a, Bupivacaine HCl Treatment 1c, Tapentadol IR, Oxycodone IR, and others.
• August 2023: Paion UK Ltd announced a study of phase 3 clinical trials for Morphine 6-glucuronide. To compare the incidence and severity of nausea in the study treatment groups, during the 18-hour period starting 6 hours after titration to pain relief; following confirmation of the assumption of non-inferiority between the two groups of pain relief over the 24 hour post-operative period. Pain relief and nausea will be determined by measuring the areas under the curves of pain intensity and nausea verbal rating scale scores.
• September 2023: Allay Therapeutics Inc. announced a study of phase 2 clinical trials for ATX-101. This is a Phase 2B randomized, double blind, active controlled, multi-center clinical trial to evaluate the safety and efficacy of ATX-101 in participants following total knee arthroplasty. The following is short title and acronym for the study: Study Assessing Pain Relief after Replacement of the Knee (SPARK).

 

Discover more about therapies set to grab major Postoperative Pain Market Share @ Postoperative Pain Market Size

 

Postoperative Pain Overview

Postoperative Pain is an anticipated and temporary increase in background pain following surgical procedures. It is a type of pain that typically lasts less than a few days to months or pain directly related to soft tissue damage such as a sprained ankle or a paper cut. The pain is of short duration, but it gradually resolves as the injured tissues heal.

 

Postoperative Pain Epidemiology Segmentation in the 7MM

• Total Number of Surgical Procedures
• Total Number of Incident Cases
• Postoperative Pain Severity-specific Incident Cases

 

Download the report to understand which factors are driving Postoperative Pain Epidemiology Trends @ Postoperative Pain Epidemiological Insights

 

Postoperative Pain Marketed Drugs

• DEXTENZA (dexamethasone): Ocular Therapeutix
• ZYNRELEF (bupivacaine and meloxicam): Heron Therapeutics

 

Postoperative Pain Emerging Drugs

• SVT-15473 (clobetasol propionate ophthalmic nanoemulsion 0.05%): Salvat Laboratories
• TLC590: Taiwan Liposome Company

 

To know more about Postoperative Pain Treatment options, visit @ Postoperative Pain Drugs

 

Postoperative Pain Treatment Market

The current Postoperative Pain treatment consists of different approaches classified into pharmacologic and nonpharmacological therapies. The pharmacological therapies include analgesics that are further segregated into opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, corticosteroids, anesthetics, etc. Acute pain is also managed by the use of benzodiazepines, muscle relaxants, antidepressants, alpha-2 agonists, gamma-aminobutyric agonists, and cannabinoids.

 

Postoperative Pain Market Outlook

Effective pain relief is of the utmost importance in treating patients undergoing surgery. Pain relief has significant physiological benefits; hence, monitoring pain relief is increasingly becoming a crucial postoperative quality measure. Postoperative pain management aims to reduce or eliminate pain and discomfort with minimal side effects. Most surgical patients experience acute postoperative pain, but evidence suggests that less than half report adequate postoperative pain relief. Many preoperative, intra-operative, and postoperative interventions and management strategies are available for reducing and managing postoperative pain.

 

Learn more about the Postoperative Pain Pipeline Therapies in clinical trials @ Postoperative Pain Market Landscape

 

Scope of the Postoperative Pain Market Research Report

• Coverage- 7MM
• Study Period- 2019-2032
• Postoperative Pain Companies- Taiwan Liposome Company, Teikoku Pharma USA, Novartis Pharmaceuticals, Concentric Analgesics, Mati Therapeutics, Arthritis Innovation Corporation, MedinCell, Surface Ophthalmics, Salvat Laboratories, Grünenthal, Vertex Pharmaceuticals, Formosa Pharmaceuticals, Oculis, Neumentum Pharmaceuticals, Charleston Laboratories, and others.
• Postoperative Pain Pipeline Therapies- SABER-Bupivacaine Treatment 1a, Bupivacaine HCl Treatment 1c, Tapentadol IR, Oxycodone IR, and others.
• Postoperative Pain Market Dynamics: Postoperative Pain Market Drivers and Barriers
• Postoperative Pain Market Access and Reimbursement, Unmet Needs, and Future Perspectives

 

Discover more about Postoperative Pain Drugs in development @ Postoperative Pain Ongoing Clinical Trials Analysis

 

Table of Content

1. Report Introduction

2. Postoperative Pain Market Overview at a Glance

3. Executive Summary of Postoperative Pain

4. Key Events

5. Disease Background and Overview

6. Treatment

7. Epidemiology and Patient Population

8. Patient Journey

9. Postoperative Pain Marketed Drugs

10. Postoperative Pain Emerging Drugs

11. Postoperative Pain: Seven Major Market Analysis

12. Postoperative Pain KOL Views

13. Postoperative Pain SWOT Analysis

14. Postoperative Pain Unmet Needs

15. Reimbursement and Postoperative Pain Market Access

16. Appendix

17. DelveInsight Capabilities

18. Disclaimer

19. About DelveInsight

 

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Healthcare Market Research Reports, Competitive Landscaping, and Mergers and acquisitions.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/consulting/ci-tracking